Skip to content
Doseworth
Menu

FDA warning letter · #716505

eDrugstore: What the FDA Letter Means for What You Pay

Activetirzepatide
Status

Operating

Concerns

marketing / labeling

Issued

September 2025

Response logged

Not logged

By Marla Whitfield, Pricing Editor

Primary source

Read the original letter on fda.gov →

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/edrugstore-716505-09092025

What FDA cited

Quoted verbatim from the letter dated

Read the full letter →

This letter is to advise you that the United States Food and Drug Administration (FDA) reviewed your website content at the internet address https://www.edrugstore.com in August 2025 and has observed that your website offers various compounded drug products, including tirzepatide.

  1. 1

    "FDA-Approved Active"

  2. 2

    "eDrugstore guarantees that all Tirzepatide medications are genuine, FDA-approved formulations for maximum efficacy and safety."

  3. 3

    "Tirzepatide (Zepbound)…."

  4. 4

    Compounded drug products are not FDA-approved. Your claims imply that your products are the same as an FDA-approved product when they are not.

Process

How a warning letter proceeds

  1. 1

    Letter issued

    September 2025

  2. 2

    15-working-day response window

    FDA gives the company 15 working days to respond in writing.

  3. 3

    Close-out, if issued

    FDA may post one once it is satisfied the cited issues have been corrected.

Is eDrugstore still operating?

edrugstore.com returned a live storefront when we checked in August 2026, with a weight-loss category listed alongside an extensive erectile-dysfunction catalogue and an affiliate sign-in in the site header.

What this means for what you pay

Of all the wording FDA quoted across this roster, the phrase used here is the one a price shopper is most likely to be reassured by and least able to check: a guarantee that the medication is a genuine, FDA-approved formulation. A compounded drug is by definition not an FDA-approved drug — that is the structural point, and it does not depend on anything about this seller's quality. The practical takeaway is narrow and useful: an "FDA-approved" badge next to a compounded product's price is not a claim about that product's regulatory status, and FDA said as much in writing here. It is also worth knowing that the letter and the Healthy Male letter issued the same day print the same Tempe, Arizona address, so a shopper comparing the two sites is not necessarily comparing two independent operations.

Has eDrugstore responded?

As of , FDA’s public tracking for this letter does not show a logged company response. Companies are not required to make a response public, and FDA does not always update this field promptly — this is not evidence eDrugstore failed to respond.

Sources

Other letters in this index

View the full index →

Editorial disclaimer: An FDA warning letter is a public regulatory communication stating the agency's view. It is not a recall, a fine, a criminal charge, an injunction, or a finding that a company has broken the law.